Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Selleck Chemical LLC Ixazomib (MLN2238) S2180-50mg
SDP

Catalog No. 503112320
Encompass_Preferred

Ixazomib (MLN2238) inhibits the chymotrypsin-like proteolytic ( 5) site of the 20S proteasome with IC50 and Ki of 3 4 nM and 0 93 nM in cell-free assays respectively also inhibits the caspase-like ( 1) and trypsin-like ( 2) proteolytic sites with IC50 of 31 and 3500 nM Ixazomib (MLN2238) induces autophagy Phase 3

Catalog No. 50-311-2320 Supplier Selleck Chemical LLC Supplier No. S218050MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Ixazomib (MLN2238) inhibits the chymotrypsin-like proteolytic ( 5) site of the 20S proteasome with IC50 and Ki of 3 4 nM and 0 93 nM in cell-free assays respectively also inhibits the caspase-like ( 1) and trypsin-like ( 2) proteolytic sites with IC50 of 31 and 3500 nM Ixazomib (MLN2238) induces autophagy Phase 3

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.